Noncoding RNAs in chronic obstructive pulmonary disease: From pathogenesis to therapeutic targets.

Noncoding RNA Res

Central Lab of Biomedical Research Center, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310020, Zhejiang, China.

Published: December 2024

AI Article Synopsis

  • * There is a need for deeper research into the biological mechanisms of COPD to find new treatment options.
  • * Recent studies highlight the important roles of various noncoding RNAs, like miRNAs and lncRNAs, in the development of COPD, suggesting that RNA-based therapies could be a promising approach for management.

Article Abstract

Chronic obstructive pulmonary disease (COPD) is the most prevalent chronic respiratory disorder that is becoming the leading cause of morbidity and mortality on a global scale. There is an unmet need to investigate the underlying pathophysiological mechanisms and unlock novel therapeutic avenues for COPD. Recent research has shed light on the significant roles played by diverse noncoding RNAs (ncRNAs), including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), in orchestrating the development and progression of COPD. This review provides an overview of the regulatory roles of ncRNAs in COPD, elucidating their underlying mechanisms, and illuminating the potential prospects of RNA-based therapeutics in the management of COPD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254503PMC
http://dx.doi.org/10.1016/j.ncrna.2024.06.005DOI Listing

Publication Analysis

Top Keywords

noncoding rnas
12
chronic obstructive
8
obstructive pulmonary
8
pulmonary disease
8
copd
5
rnas chronic
4
disease pathogenesis
4
pathogenesis therapeutic
4
therapeutic targets
4
targets chronic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!